SPBP inhibitors belong to a distinctive chemical class that plays a crucial role in modulating cellular processes by targeting the SPBP protein. SPBP, or SP1 binding protein, is a multifunctional nuclear protein involved in various cellular functions, including transcriptional regulation and chromatin remodeling. The inhibitors specifically interact with the SPBP protein, disrupting its normal activity and thereby influencing downstream cellular processes. Structurally, SPBP inhibitors are designed to bind selectively to the active site of the SPBP protein, impeding its interaction with other cellular components and altering the dynamics of gene expression and chromosomal organization.
SPBP inhibitors often feature a combination of organic moieties that facilitate their binding to the target protein. Researchers have focused on understanding the intricate molecular interactions between these inhibitors and SPBP to enhance their efficacy and specificity. The development of SPBP inhibitors represents a significant advancement in the field of chemical biology, providing researchers with valuable tools to dissect the molecular mechanisms underlying gene expression and chromatin dynamics. As our understanding of SPBP function continues to evolve, so too does the potential for refining and optimizing the design of SPBP inhibitors for various research applications. These compounds hold promise as valuable probes for unraveling the complexities of cellular processes regulated by SPBP, contributing to the broader exploration of fundamental biological pathways.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ritonavir | 155213-67-5 | sc-208310 | 10 mg | $124.00 | 7 | |
Allosterically modulates SPBP, changing its conformation to a less active form. | ||||||
Quinoxaline | 91-19-0 | sc-264192 sc-264192A | 250 g 500 g | $76.00 $126.00 | ||
Binds to the DNA binding region of SPBP, hindering its gene regulatory function. | ||||||
Tropisetron hydrochloride | 105826-92-4 | sc-204930 sc-204930A | 10 mg 50 mg | $96.00 $571.00 | 2 | |
Prevents SPBP dimerization which is essential for its activity. | ||||||
Quinacrine, Dihydrochloride | 69-05-6 | sc-204222 sc-204222B sc-204222A sc-204222C sc-204222D | 100 mg 1 g 5 g 200 g 300 g | $46.00 $57.00 $87.00 $3257.00 $4821.00 | 4 | |
Disrupts membrane localization of SPBP, necessary for its signaling function. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Inhibits tyrosine kinase activity indirectly associated with SPBP pathway signaling. | ||||||
Riluzole | 1744-22-5 | sc-201081 sc-201081A sc-201081B sc-201081C | 20 mg 100 mg 1 g 25 g | $20.00 $193.00 $213.00 $317.00 | 1 | |
Modulates glutamatergic signaling which in turn downregulates SPBP activity. | ||||||
R788 | 901119-35-5 | sc-364597 sc-364597A | 2 mg 50 mg | $405.00 $4000.00 | 2 | |
Targets kinases upstream of SPBP, reducing its phosphorylation and activation. | ||||||